Wells Fargo Maintains Equal-Weight on CVS Health, Raises Price Target to $61
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter maintains an Equal-Weight rating on CVS Health and raises the price target from $60 to $61.
August 12, 2024 | 3:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst Stephen Baxter maintains an Equal-Weight rating on CVS Health and raises the price target from $60 to $61.
The raised price target from $60 to $61 by Wells Fargo indicates a slightly positive outlook for CVS Health. However, the Equal-Weight rating suggests that the stock is expected to perform in line with the market. This could lead to a modest positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100